BioHealth News Archive
NOT-HL-15-284: Request for Information: Optimizing the NHLBI Clinical Trials Enterprise: Performance Milestones and Metrics
NHLBI has issued the first in a series of Requests for Information (RFIs) to solicit input from its stakeholders on ways to optimize the…
Read More
Venture capital in 2015: a look back – Bridge Bank – Be bold, venture wisely.
Venky Ganeson, managing director of Menlo Ventures and future chairman of the National Venture Capital Association, told Inc. that 2015 has been the third-strongest…
Read More
Johns Hopkins Accountable Care Organization Achieves Perfect Quality Reporting Score – 12/22/2015
When the Centers for Medicare & Medicaid Services (CMS) issued their 2014 quality and financial performance results in August, an accountable care organization (ACO)…
Read More
OrbiMed Launches $950 Million Venture Capital Fund – Business Wire
OrbiMed, a leading investment firm focused on the healthcare sector, announced the closing of its next venture capital fund, OrbiMed Private Investments VI, LP,…
Read More
GSK had the biggest global health breakthrough of 2015 – Fortune
It’s taken 30 years and more than $565 million to make it happen: the first-ever malaria vaccine. The innoculation, called Mosquirix, is the first…
Read More
Alexandria Real Estate Equities: What Does It Do? – Market Realist
Headquartered in Pasadena, California, Alexandria Real Estate Equities (ARE) was founded by Joel S. Marcus and Jerry M. Sudarsky in 1994. The company is…
Read More
Medigene AG announces key Management Changes – NASDAQ.com
Chief Scientific Officer Prof Dolores Schendel appointed new Chief Executive Officer of Medigene AG Dave Lemus appointed Chief Operating Officer of Medigene AG and…
Read More
Eye cells grown at Johns Hopkins may lead to a cure for some forms of blindness – Baltimore Sun
Drs. Donald Zack and Valentin Sluch spent 30 anxious days waiting for their experiment to yield results. They were eager to see if the…
Read More
PE HUBBrace Pharma Capital leads $33 mln Series B funding in Navitor – PE HUB
Brace Pharma Capital led a $33 million Series B funding in Navitor Pharmaceuticals, a biopharmaceutical company. Other investors in the funding included Remeditex Ventures,…
Read More
2016 Health Datapalooza VII Announces Nominations for Health Data Liberators Award Now Accepted
May 8 - 11, 2016 ANNOUNCING NOMINATIONS NEW BEING ACCEPTED FOR THE HEALTH DATA LIBERATORS AWARD The Datapalooza's Health Data Liberators Award recognizes extraordinary…
Read More
Baltimore health IT firm DinnerTime lands contract with Evergreen Health Co-op – Baltimore Business Journal
It’s hard to get people to eat right. Healthy food can be expensive and time consuming to prepare. {iframe}http://www.bizjournals.com/baltimore/blog/cyberbizblog/2015/12/baltimore-health-it-firm-dinnertime-lands-contract.html{/iframe}
Read More
GSK to buy HIV drugs from Bristol-Myers Squibb for initial $350 million – Reuters
Pharmaceutical group GlaxoSmithKline said its majority-owned HIV business would buy drugs at different stages of development from U.S. rival Bristol-Myers Squibb for an initial…
Read More
AstraZeneca invests in China to speed up delivery of innovative biologics & targeted medicines
AstraZeneca along with MedImmune, its global biologics research and development arm, announced a range of strategic initiatives to accelerate the delivery of innovative biologics…
Read More
Open House For Spring Technology Transfer Courses at the FAES Graduate School at NIH
On Thursday, January 14th from 4-6:30pm pm there will be an open house for the spring courses in the “Advanced Studies in Technology Transfer”…
Read More
Is the FDA really slowing down new drug innovation? – Vox
On Monday, I wrote about a new bill introduced by Sens. Ted Cruz (R-TX) and Mike Lee (R-UT) to overhaul the Food and Drug…
Read More